| Title |
Author |
Type |
Date |
Words |
| Oncolytics Biotech[R] Inc. Signs Sponsorship Pact with NCIC CTG. |
|
Clinical report |
May 31, 2012 |
379 |
| Exelixis Initiates COMET-1 Pivotal Trial Focused on Overall Survival in Men With Advanced Prostate Cancer. |
|
|
May 30, 2012 |
1478 |
| Biocept to Present Clinical Findings on Circulating Tumor Cells (CTCs) at the American Society for Clinical Oncology Annual Meeting. |
|
|
May 30, 2012 |
865 |
| Exelixis Completes Submission of New Drug Application for Cabozantinib for the Treatment of Medullary Thyroid Cancer. |
|
|
May 30, 2012 |
851 |
| Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO. |
|
|
May 29, 2012 |
1555 |
| Botanical formula 'may slow down breast cancer metastasis'. |
|
|
May 27, 2012 |
313 |
| Research and Markets: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2012. |
|
|
May 24, 2012 |
408 |
| Bayer Submits New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer. |
|
|
May 23, 2012 |
1130 |
| New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer Submitted by Bayer. |
|
|
May 23, 2012 |
1263 |
| Research and Markets: Metastatic Lung Cancer - Pipeline Review, H1 2012. |
|
|
May 22, 2012 |
399 |
| Winning The Battle Against Breast Cancer Metastasis. |
|
|
May 22, 2012 |
600 |
| 600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical Phase III Study. |
|
Clinical report |
May 21, 2012 |
1490 |
| Dendreon Announces Data Presentation at the 2012 American Urological Association Annual Meeting. |
|
|
May 21, 2012 |
1695 |
| Active Biotech and Ipsen to Present Tasquinimod Phase II Overall Survival Data at the 2012 ASCO Annual Meeting. |
|
Conference news |
May 18, 2012 |
1344 |
| Synta Announces Presentations at the 2012 American Society for Clinical Oncology (ASCO) Annual Meeting. |
|
|
May 17, 2012 |
602 |
| Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting. |
|
|
May 17, 2012 |
393 |
| Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012. |
|
|
May 16, 2012 |
3837 |
| Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer. |
|
Clinical report |
May 16, 2012 |
2044 |
| Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma. |
|
|
May 15, 2012 |
959 |
| GTx Announces Removal of Full Clinical Hold By FDA for Capesaris[R] In Advanced Prostate Cancer. |
|
|
May 8, 2012 |
773 |
| In 2020, FOLFIRI Plus Ramucirumab Will Earn Decision Resources' Proprietary Clinical Gold-Standard Status for the Second-Line Treatment of Metastatic Colorectal Cancer. |
|
|
May 8, 2012 |
770 |
| Research and Markets: Metastatic Brain Tumor - Pipeline Review, H1 2012. |
|
|
May 8, 2012 |
400 |
| In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells. |
Oliveira, Jaqueline Carvalho, de; Brassesco, Maria, Sol; Pezuk, Julia Alejandra; Morales, Andressa G |
Report |
May 1, 2012 |
3781 |
| Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety. |
Martin, George M.; Stockfleth, Eggert |
|
May 1, 2012 |
6596 |
| Lessons of leprosy: the emergence of TH17 Cytokines during type II reactions (ENL) is teaching us about T-cell plasticity. |
Martiniuk, Frank; Giovinazzo, Jerome; Tan, Ainah U.; Shahidullah, Rozana; Haslett, Patrick; Kaplan, |
Report |
May 1, 2012 |
3198 |
| ZIOPHARM Oncology Provides Update on PICASSO 3 Trial. |
|
|
May 1, 2012 |
753 |
| Eisai Forms Partnership with Valeant for Halaven(R). |
|
|
May 1, 2012 |
758 |
| Altor BioScience and the Melanoma Research Alliance to Co-Support Clinical Studies of Altor's Novel IL-15 Superagonist for Metastatic Melanoma. |
|
Clinical report |
Apr 30, 2012 |
423 |
| BioAlliance Pharma Announces Two New Key Steps in the Development of Its AMEP[R] Biotherapy. |
|
|
Apr 26, 2012 |
827 |
| German Federal Regulator Confirms Additional Benefit of Anti-cancer Agent Halaven(R) for Metastatic or Locally Advanced Breast Cancer. |
|
|
Apr 24, 2012 |
1005 |
| Visioneer "Where There Is a Need" Program Supports the National Brain Tumor Society. |
|
|
Apr 17, 2012 |
836 |
| For the Treatment of Advanced Non-Small-Cell Lung Cancer, Medical Oncologists Report That They are Rapidly Adopting the ALK-Positive Test into Their Treatment Practices to Identify Appropriate Patients for Xalkori (crizotinib). |
|
|
Apr 16, 2012 |
681 |
| The man who conquered the EoACAyemperor of all maladies'. |
|
|
Apr 14, 2012 |
420 |
| WIDOWER'S pounds 95K COMPO. |
|
|
Apr 6, 2012 |
149 |
| Eisai Enters into Partnership with PharmaSwiss for Halaven (Eribulin) Promotion and Distribution in Central and Eastern European Countries. |
|
|
Apr 5, 2012 |
364 |
| BIND Biosciences Presents Clinical Data on BIND-014 Promising Anti-tumor Effects in Patients with Advanced or Metastatic Cancers. |
|
|
Apr 4, 2012 |
1339 |
| BIND Biosciences Publishes Data on BIND-014, the First Targeted and Programmable Nanomedicine to Show Clinical Anti-Tumor Effects. |
|
Clinical report |
Apr 4, 2012 |
1175 |
| Docetaxel Dominates First-Line Metastatic Castrate-Resistant Prostate Cancer Treatment, But Total Patient Share of Zytiga and Jevtana Reach Nearly 50 Percent in the Second and Third-Line Settings According to Surveyed Physicians. |
|
Clinical report |
Apr 3, 2012 |
732 |
| `Intimate relationship` between metastatic breast cancer and arthritis identified. |
|
|
Apr 2, 2012 |
645 |
| Dairy & prostate cancer. |
|
Brief article |
Apr 1, 2012 |
174 |
| War on cancer. |
Moss, Ralph |
|
Apr 1, 2012 |
2170 |
| Chemopreventive properties of apple Procyanidins on human colon cancer-derived Metastatic sw620 cells and in a rat model of colon carcinogenesis. |
|
|
Apr 1, 2012 |
278 |
| A rare case of non-metastatic cholangiocarcinoma in a long standing choledochal cyst. |
Goukassian, I.D.; Kussman, S.R.; Toribo, Y.; McAneny, D.B.; Rosen, J.E. |
Case study |
Apr 1, 2012 |
1246 |
| Germ cell tumor metastatic to the oral cavity. |
Lee, Luis; Oppenheimer, Randy; Jayaram, Lakshmi |
Case study |
Apr 1, 2012 |
1161 |
| Genentech's Trastuzumab Emtansine (T-DM1) Showed Positive Phase III Results In HER2-Positive Metastatic Breast Cancer. |
|
Clinical report |
Mar 30, 2012 |
911 |
| Study Establishes Safety and Clinical Benefit of SIR-Spheres[R] microspheres in Treating Metastatic Liver Tumors in Patients who Failed Systemic Chemotherapy. |
|
Clinical report |
Mar 27, 2012 |
615 |
| Clovis Oncology Completes Enrollment in Pivotal LEAP Trial of CO-101 versus Gemcitabine in Metastatic Pancreatic Cancer. |
|
|
Mar 26, 2012 |
1361 |
| DFINE Introduces STAR Tumor Ablation System at SIR 2012. |
|
|
Mar 22, 2012 |
937 |
| Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas. |
|
|
Mar 20, 2012 |
1083 |
| DFINE Announces First U.S. Patient Treated with the STAR Ablation System. |
|
|
Mar 14, 2012 |
1048 |
| Completed Pancreatic Cancer Phase 1-2 Trial Concluded the Encapsulated Cells Produced Chemotherapy That May Treat Downstream Micro Metastatic Disease. |
|
|
Mar 13, 2012 |
730 |
| Systemic Tumor Disappearance Following Local Radiation Treatment. |
|
|
Mar 12, 2012 |
623 |
| BioSante's Prostate Cancer Vaccine Resulted in Stable Disease in Over 50% of Patients in Newly Published Study. |
|
Clinical report |
Mar 5, 2012 |
955 |
| Exelixis Announces Initiation of Investigator-Sponsored Clinical Trial Combining Cabozantinib and Abiraterone in Men With Castration-Resistant Prostate Cancer. |
|
|
Mar 5, 2012 |
1670 |
| Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation. |
Yoon, Ji-Hae; Choi, Yeo-Jin; Cha, Seon-Woo; Lee, Seong-Gene |
|
Mar 1, 2012 |
5690 |
| Salidroside inhibits migration and invasion of human fibrosarcoma HT1083 cells. |
Sun, Chao; Wang, Zhenhua; Zheng, Qiusheng; Zhang, Hong |
Report |
Mar 1, 2012 |
6191 |
| Metastatic carcinoma as an unusual cause of failure in total hip arthroplasty. |
Pereira, A.; Massada, M.; Sousa, R.; Lemos, R. |
Case study |
Mar 1, 2012 |
988 |
| Phase 3 trial of PV-10 for metastatic melanoma. |
|
Brief article |
Mar 1, 2012 |
113 |
| The effects of tumor size, degree of differentiation, and depth of invasion on the risk of neck node metastasis in squamous cell carcinoma of the oral cavity. |
Haksever, Mehmet; Inancli, Hasan Mete; Tuncel, Umit; Kurcuoglu, Sefik Sinan; Uyar, Melek; Genc, Omer |
Report |
Mar 1, 2012 |
4219 |
| Research and Markets: Metastatic Brain Tumor Global Clinical Trials Review, H1, 2012. |
|
|
Feb 28, 2012 |
348 |
| Dual Inhibition of MET and VEGF Signaling With Cabozantinib Blocks Tumor Invasiveness and Metastasis. |
|
|
Feb 24, 2012 |
1289 |
| Active Biotech and Ipsen Report Tasquinimod (TASQ) Phase II Long Term Safety Data at the 27th European Association of Urology (EAU) Congress. |
|
Clinical report |
Feb 24, 2012 |
1375 |
| Plexxikon Announces European Approval of Zelboraf[R] for the Treatment of Patients With BRAF Mutation-Positive Metastatic Melanoma. |
|
|
Feb 20, 2012 |
1467 |
| Prostate cancer patients get access to breakthrough treatment. |
|
|
Feb 20, 2012 |
375 |
| Research and Markets: Metastatic Pancreatic Cancer - Pipeline Review, H1 2012. |
|
|
Feb 15, 2012 |
449 |
| Tiltan Pharma Commences Phase 2 Clinical Study of Anti-Angiogenic Treatment for Pancreatic Cancer. |
|
|
Feb 13, 2012 |
746 |
| Amgen to Discuss Application for New Use of XGEVA?A (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting. |
|
|
Feb 8, 2012 |
2320 |
| Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis[logical not]" Immunotherapy AGS-003 in Combination with Sunitinib in Patients with Metastatic Renal Cell Carcinoma (mRCC). |
|
Clinical report |
Feb 4, 2012 |
711 |
| Phase 1 Study of OGX-427 Presented at the ASCO 2012 Genitourinary Cancers Symposium Shows Early Evidence of Activity in Bladder Cancer. |
|
|
Feb 2, 2012 |
988 |
| Intestinal metastasis from primary epidermoid anal carcinoma in a 34 year old male presented with acute bowel obstruction. |
Abdulmajed, M.; Ghalib, A.; Mohamed, M.; Marsh, P. |
Case study |
Feb 1, 2012 |
1149 |
| Atypical carcinoid (moderately differentiated neuroendocrine carcinoma) of the uvula. |
Goldman, Nelson C.; Barnes, Robert E., Jr. |
Case study |
Feb 1, 2012 |
1043 |
| Managing lymphoedema in palliative care patients: a collaborative approach to the care of palliative patients with lymphoedema has had encouraging results. |
Walker, Jackie; Thomson, Mary |
Report |
Feb 1, 2012 |
1945 |
| Paclitaxel-associated subungual pyogenic granuloma: report in a patient with breast cancer receiving Paclitaxel and review of drug-induced pyogenic granulomas adjacent and beneath the nail. |
Paul, Laura J.; Cohen, Philip R. |
Clinical report |
Feb 1, 2012 |
3364 |
| Novel therapies for the treatment of metastatic melanoma. |
Chouake, Jason; Friedman, Adam |
Report |
Feb 1, 2012 |
2290 |
| FDA to Review Potential New Use of XGEVA. |
|
Clinical report |
Jan 31, 2012 |
1258 |
| New Breast Cancer Treatment Available in Italy. |
|
|
Jan 25, 2012 |
1944 |
| InSightec Submits Pre Market Application (PMA) for FDA Approval of ExAblate for Treatment of Painful Bone Metastases. |
|
|
Jan 24, 2012 |
655 |
| Provectus Receives Guidance From FDA On Pathway to Approval for Phase 3 Trial of PV-10 For Metastatic Melanoma. |
|
|
Jan 18, 2012 |
1283 |
| Drug Improves Survival of Colorectal Cancer Patients, Trial Results Show. |
|
|
Jan 17, 2012 |
472 |
| Despite No Current Approval of Janssen's Zytiga in Asymptomatic/Minimally Symptomatic MCRPC, 31% of Surveyed Physicians Report Decreased Use of Dendreon's Provenge Because Zytiga is Available for Later Lines of Treatment. |
|
|
Jan 16, 2012 |
550 |
| Research and Markets: Launch of New Targeted Therapeutics Will Drive Market Growth During the Forecast Period 2010-2017. |
|
Industry overview |
Jan 11, 2012 |
423 |
| Clovis Oncology Announces Size of Initial hENT1-Low Population in Pivotal LEAP Trial and Provides Financial Guidance for 2012. |
|
|
Jan 9, 2012 |
1103 |
| Research and Markets: Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2012 Market Report. |
|
Report |
Jan 9, 2012 |
392 |
| Eisai Inc. Receives J-Code from CMS for Halaven[R] (eribulin mesylate) Injection. |
|
|
Jan 3, 2012 |
950 |
| New Randox molecular diagnostic test enables selection of CRC patients for anti-EGFR therapy. |
|
Brief article |
Jan 1, 2012 |
240 |
| Targeted therapies in breast cancer: tailoring treatment to the molecular drivers of disease progression. |
Hicks, David G. |
Report |
Jan 1, 2012 |
1911 |
| FDA to Review Potential New Use of XGEVA[c]A (Denosumab) at Oncologic Drugs Advisory Committee Meeting. |
|
Clinical report |
Dec 29, 2011 |
2435 |
| AVEO Announces Patient Enrollment in Phase 2 Clinical Trial of Tivozanib in Combination with mFOLFOX6 in Patients with Advanced Colorectal Cancer. |
|
|
Dec 22, 2011 |
1290 |
| Celldex Completes Accrual of CDX-011 Phase 2b "EMERGE" Study in Advanced Breast Cancer. |
|
|
Dec 21, 2011 |
1185 |
| Response Genetics, Inc. to Offer FDA-Approved ALK Test for metastatic NSCLC. |
|
|
Dec 21, 2011 |
681 |
| Eisai Announces Canadian Approval of its Anticancer Agent Halaven. |
|
|
Dec 15, 2011 |
494 |
| ResearchMoz: Optimizing Treatment for Bone Metastases in Patients With Advanced Cancers. |
|
|
Dec 13, 2011 |
1062 |
| Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer. |
|
|
Dec 12, 2011 |
1358 |
| Ganetespib Potently Inhibits Multiple Signaling Pathways Active in Breast Cancer. |
|
Clinical report |
Dec 12, 2011 |
1050 |
| Research and Markets: Circulating Tumor Cells (CTCs) Market Trends 2011. |
|
|
Dec 12, 2011 |
363 |
| Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium. |
|
|
Dec 9, 2011 |
1786 |
| Spectrum Pharmaceuticals Affirms Strong Patent Protection for FUSILEV[R] (levoleucovorin) Through December 31, 2019. |
|
|
Dec 9, 2011 |
1157 |
| Ganetespib Shows Clinical Activity in HER2+ and Triple Negative Metastatic Breast Cancer. |
|
|
Dec 8, 2011 |
1491 |
| Novel Cancer Treatment Combination Receives Approval to Begin First-in-Human Testing for Patients with Advanced Metastatic Melanoma. |
|
|
Dec 8, 2011 |
1149 |
| Exelixis' Cabozantinib Shows Encouraging Clinical Activity in Patients With Metastatic Breast Cancer. |
|
|
Dec 7, 2011 |
1301 |
| Genentech Announces Positive Results of Pivotal Phase III Study with pertuzumab in HER2-Positive Metastatic Breast Cancer. |
|
Clinical report |
Dec 7, 2011 |
2120 |
| Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes. |
|
|
Dec 6, 2011 |
865 |
| Research and Markets: Bone Metastasis Global Clinical Trials Review, H2, 2011. |
|
|
Dec 1, 2011 |
339 |
| Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences. |
|
Clinical report |
Dec 1, 2011 |
1456 |
| US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium. |
|
|
Dec 1, 2011 |
1146 |
| War on cancer. |
Moss, Ralph |
|
Dec 1, 2011 |
2436 |
| Thyroid carcinoma with intravascular metastasis to the internal jugular vein. |
Osborne, Ryan F.; Zandifar, Hootan; Gupta, Reena |
Case study |
Dec 1, 2011 |
462 |
| Metastatic malignant melanoma causing ileo-ileal intussusception. |
Yerrakalya, D.; Ackroyd, R.; Lee, F. |
Case study |
Dec 1, 2011 |
841 |
| Primary lung cancer presenting as metastasis to the big toe. |
Nicholson, S.; Mohamed, I.; Tahir, A.; Antunes, G. |
Case study |
Dec 1, 2011 |
1244 |
| Embryoprotein TWIST distribution in breast cancer cells MDA-MB-231 treated with 5-Fluorouracil and malnutrition. |
Escobar-Cabrera, Jesica; Rodriguez-Torres, Angelina; Berumen-Segura, Laura; Alcocer, Guadalupe Garci |
Report |
Dec 1, 2011 |
2525 |
| Grants for cancer docs announced; RESEARCH. |
|
|
Nov 30, 2011 |
106 |
| Provectus Reports on Third End-of-Phase 2 Meeting with U.S. FDA to Define Pathway to Approval of PV-10 for Metastatic Melanoma. |
|
|
Nov 29, 2011 |
657 |
| Research and Markets: Optimizing Treatment for Bone Metastases in Advanced Cancers 2011. |
|
|
Nov 29, 2011 |
452 |
| Biodesix Announces New VeriStrat Data to be Presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. |
|
|
Nov 22, 2011 |
678 |
| Exelixis Announces Initiation of Phase 2 Investigator-Sponsored Trial of Cabozantinib in Women with Hormone Receptor-Positive Metastatic Breast Cancer and Bone Metastases. |
|
|
Nov 21, 2011 |
1722 |
| Translational Sciences Corporation Receives FDA 510(k) Clearance for Commercialization of OncoTrac(TM) in the United States. |
|
|
Nov 21, 2011 |
522 |
| Susan G. Komen for the Cure[R] Statement on U.S. Food and Drug Administration's Decision Removing Avastin from Approved Breast Cancer Drugs. |
|
|
Nov 18, 2011 |
392 |
| FDA Commissioner Announces Final Decision on Avastin for Metastatic Breast Cancer. |
|
|
Nov 18, 2011 |
1984 |
| Women With Advanced Breast Cancer Denied Life-extending Treatment Halaven(R) (black triangle drug) (Eribulin). |
|
|
Nov 16, 2011 |
1990 |
| Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs). |
|
Clinical report |
Nov 15, 2011 |
664 |
| Vectibix (Panitumumab) Granted Approval for Expanded Indications in the European Union. |
|
|
Nov 15, 2011 |
2553 |
| The Lancet Publishes Results Demonstrating XGEVA Significantly Prolonged Bone Metastasis-free Survival in Men With Prostate Cancer. |
|
|
Nov 15, 2011 |
2344 |
| Data on Provectus's PV-10 For Metastatic Melanoma Presented at the 2011 International Melanoma Congress. |
|
|
Nov 14, 2011 |
642 |
| Medical Oncologists Have Rapidly Adopted Yervoy and Zelboraf in All Lines of Therapy for the Treatment of Metastatic Melanoma. |
|
|
Nov 14, 2011 |
785 |
| Preliminary Data Demonstrate that 40 mg Daily Dose of Cabozantinib Yields a High Rate of Bone Scan Response in mCRPC. |
|
|
Nov 12, 2011 |
2085 |
| Exelixis' Cabozantinib Phase 2 Data Demonstrate Reduction in Bone Pain and Narcotic Analgesic Use in Patients with Previously Treated mCRPC. |
|
|
Nov 12, 2011 |
1833 |
| Protein behind galloping breast cancer spread identified. |
|
|
Nov 11, 2011 |
283 |
| Phase 2 Data on Provectus's PV-10 for Metastatic Melanoma Will Be Presented at the 2011 International Melanoma Congress on November 12, 2011. |
|
|
Nov 10, 2011 |
489 |
| FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer. |
|
|
Nov 7, 2011 |
729 |
| A review of the chemopreventative effects of oral retinoids for internal neoplasms. |
Bhutani, Tina; Koo, John |
Clinical report |
Nov 1, 2011 |
6124 |
| Oral Bisphenol a increases mammary carcinogenesis and metastasis in mice. |
|
Brief article |
Nov 1, 2011 |
178 |
| Chronic oral exposure to bisphenol a results in a nonmonotonic dose responsein in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. |
Jenkins, Sarah; Wang, Jun; Eltoum, Isam; Desmond, Renee; Lamartiniere, Coral A. |
Report |
Nov 1, 2011 |
6512 |
| The inflammatory factor underlying most cancers. |
Hoffnung, David |
|
Nov 1, 2011 |
4346 |
| BerGenBio Initiates Preclinical Development of Novel AXL Inhibitor BGB324. |
|
|
Oct 31, 2011 |
487 |
| Key protein fuelling growth of cancer identified. |
|
|
Oct 31, 2011 |
317 |
| Exelixis to Initiate Cabozantinib '306 Trial with Pain Endpoint in mCRPC. |
|
|
Oct 31, 2011 |
2021 |
| ATLAB Pharma and BZL Biologics Announce Exclusive Global Licensing Agreement for Lu-J591, a Novel Radiopharmaceutical in Phase IIB for the Treatment of Prostate Cancer. |
|
Clinical report |
Oct 28, 2011 |
648 |
| Research and Markets: Abiraterone - Comprehensive Patent Search. |
|
|
Oct 28, 2011 |
704 |
| Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival. |
|
|
Oct 26, 2011 |
1298 |
| Pancreatic Cancer Drug Pioneered by NantWorks Chairman Patrick Soon-Shiong Shows Encouraging Trial Results. |
|
|
Oct 25, 2011 |
499 |
| Data From Phase 2 Clinical Studies of Telotristat Etiprate in Patients With Carcinoid Syndrome to be Presented at North American Neuroendocrine Tumor Society Meeting. |
|
Clinical report |
Oct 21, 2011 |
678 |
| A case of complete spontaneous regression of extremely advanced Merkel cell carcinoma. |
Sugamata, A.; Goya, K.; Yoshizawa, N. |
Case study |
Oct 21, 2011 |
942 |
| Serono Symposia International Foundation (SSIF) : Multidisciplinary Approach to Managing Liver Metastases From Colorectal Cancer: Focus on Resectability and Combined Chemotherapy and Surgery-the 'OncoSurge' Approach. |
|
|
Oct 20, 2011 |
528 |
| Advaxis Announces Notice of Allowance of US Patent for ADXS-HPV Immunotherapy. |
|
|
Oct 18, 2011 |
635 |
| Theracrine Announces Publication Identifying Potential Novel Cancer Spread Target. |
|
|
Oct 17, 2011 |
943 |
| An online documentation for specific courses of therapy in oncology: www.bestcase-oncology.com. |
Muller-Hubenthal, Boris |
Brief article |
Oct 15, 2011 |
283 |
| Scottish Medicines Consortium Rules Against Breast Cancer Treatment Halaven(black triangle drug) (eribulin). |
|
|
Oct 10, 2011 |
1808 |
| International Research Team Reports Encouraging Results from Phase II Study of Image-Guided Stereotactic Radiosurgery for Spine Metastases. |
|
|
Oct 6, 2011 |
791 |
| International Research Team Reports Encouraging Results from Phase II Study of Image-Guided Stereotactic Radiosurgery for Spine Metastases. |
|
|
Oct 6, 2011 |
801 |
| Journal of Clinical Oncology Publishes Phase 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Capecitabine in Patients with Metastatic Colorectal Cancer. |
|
|
Oct 5, 2011 |
948 |
| Research and Markets: Metastatic Melanoma: Pipeline Assessment and Market Potential through 2017. |
|
|
Oct 4, 2011 |
461 |
| Geriatric oncology: the elephant in the empty room. |
Waghter, kerri |
|
Oct 1, 2011 |
279 |
| Topline Results: A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer. |
|
Clinical report |
Sep 30, 2011 |
802 |
| The National Institute for Health and Clinical Excellence (NICE) Issues Negative Appraisal Consultation Document (ACD) for JEVTANA (cabazitaxel). |
|
|
Sep 29, 2011 |
553 |
| Rexahn Pharmaceuticals Completes Patient Enrollment for Archexin Phase II Clinical Trial in Metastatic Pancreatic Cancer. |
|
|
Sep 28, 2011 |
649 |
| Study by Ocala Oncology/The US Oncology Network Shows Use of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Improves Overall Survival. |
|
|
Sep 28, 2011 |
1097 |
| Biocept Publishes on Mechanics and Performance of Its OncoCEE(TM) Platform for Circulating Tumor Cells (CTCs) in Cancer Patients. |
|
|
Sep 28, 2011 |
378 |
| Interim Data Announced for BIBF 1120 as Compared to bevacizumab in Combination Chemotherapy in Metastatic Colorectal Cancer. |
|
|
Sep 27, 2011 |
1445 |
| Drug combo prolongs progression-free survival time in breast cancer. |
|
|
Sep 26, 2011 |
293 |
| Antibody-guided drug 'delays breast cancer progression in trials'. |
|
|
Sep 25, 2011 |
247 |
| Delcath Announces Further Results From Neuroendocrine Tumor Cohort Presented at European Multidisciplinary Cancer Congress. |
|
Financial report |
Sep 25, 2011 |
1237 |
| Delcath Announces Further Results From Neuroendocrine Tumor Cohort Presented at European Multidisciplinary Cancer Congress. |
|
Financial report |
Sep 25, 2011 |
1357 |
| Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress. |
|
|
Sep 23, 2011 |
1069 |
| Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress. |
|
|
Sep 23, 2011 |
1208 |
| YES! deLIVERs HOPE and Awareness for People Living with Liver Tumors at Debbie Durkin's ECO Emmys. |
|
|
Sep 22, 2011 |
472 |
| Mylan Announces XELODA Settlement and License Agreement. |
|
|
Sep 21, 2011 |
410 |
| Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339. |
|
|
Sep 20, 2011 |
969 |
| Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339. |
|
|
Sep 20, 2011 |
1120 |
| Silicon Biosystems Announces Agreement with Fox Chase Cancer Center. |
|
Company overview |
Sep 20, 2011 |
627 |
| Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presented at CIRSE. |
|
|
Sep 13, 2011 |
1270 |
| The Zacks Analyst Blog Highlights: Enzon Pharmaceuticals, Merck, Pfizer, UCB Pharma and Eastman Chemical Company. |
|
|
Sep 13, 2011 |
1442 |
| BioAlliance Pharma announces positive preliminary phase I clinical results with its AMEP[R] biotherapy for metastatic melanoma. |
|
|
Sep 13, 2011 |
990 |
| Curis Announces Submission of New Drug Application by Collaborator Genentech for Vismodegib in Advanced Basal Cell Carcinoma. |
|
|
Sep 12, 2011 |
1989 |
| Positive Phase 2 Trial Results From Neuroendocrine Tumor Cohort Presented at CIRSE. |
|
|
Sep 12, 2011 |
1294 |
| Positive Phase 2 Trial Results From Neuroendocrine Tumor Cohort Presented at CIRSE. |
|
|
Sep 12, 2011 |
1418 |
| Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium. |
|
Clinical report |
Sep 9, 2011 |
1836 |
| Zytiga Approved in the European Union for Metastatic Castration-Resistant Prostate Cancer. |
|
|
Sep 7, 2011 |
1582 |
| Sarah Cannon Research Institute (SCRI) Abstract Accepted for Presentation at ASCO Breast Cancer Symposium. |
|
Clinical report |
Sep 7, 2011 |
589 |
| Research and Markets: Bone Metastasis Global Clinical Trials Review, Q2, 2011 - Providing a Detailed Overview of Bone Metastasis Clinical Trials Globally. |
|
|
Sep 6, 2011 |
426 |
| Syndax Pharmaceutical's Positive Phase 2 Data Supports Potential for Entinostat in Advanced Breast Cancer. |
|
|
Sep 6, 2011 |
1449 |
| Recurrent primary fallopian tube carcinoma presenting with an appendiceal metastasis. |
Moller, J.S.; Basson, J.I.; Duminy, J.L.; Potgieter, E. |
Case study |
Sep 1, 2011 |
575 |
| Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System. |
|
|
Sep 1, 2011 |
1303 |
| QIAGEN/Pfizer to Develop Diagnostic Compound for Lung Cancer. |
|
|
Sep 1, 2011 |
792 |
| Pigmentary changes in a patient treated with imatinib. |
Balagua, Yevgeniy; Pulitzer, Melissa P.; Maki, Robret G.; Myskowski, Patricia L. |
Case study |
Sep 1, 2011 |
2750 |
| Cervical thymic cyst presenting as a possible cystic nodal metastasis of papillary carcinoma in a 53-year-old man. |
Na, Woong; Jang, Si-Hyong; Min, Kyueng-Whan; Cho, Seok Hyun; Paik, Seung Sam |
Case study |
Sep 1, 2011 |
910 |
| Bone metastases, henna head, & the senses. |
Grundoon, Christine |
|
Sep 1, 2011 |
640 |
| Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study. |
Farham, Bridget |
Clinical report |
Sep 1, 2011 |
318 |
| What is your diagnosis? |
Nevarez, Javier G.; Cho, Doo-Youn; Tully, Thomas N., Jr. |
Report |
Sep 1, 2011 |
1385 |
| FDA Approval of XALKORI (crizotinib) and Invitation to Media Briefing from Pfizer. |
|
|
Aug 29, 2011 |
487 |
| U.S. Food And Drug Administration Approves Pfizer's XALKORI[R] (crizotinib) As First And Only Therapy Specifically For Patients With Locally Advanced Or Metastatic ALK-Positive Non-Small Cell Lung Cancer. |
|
|
Aug 26, 2011 |
3094 |
| FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer. |
|
|
Aug 26, 2011 |
1101 |
| Aethlon Medical Announces Sarcoma, Lung Cancer, Prostate Cancer, Metastatic Melanoma, and Head and Neck Cancer Studies. |
|
|
Aug 24, 2011 |
1106 |
| Interest High for Novel Treatment Options in Development for Metastatic Breast Cancer, According to Oncology Tracking Study by GfK HealthCare. |
|
|
Aug 24, 2011 |
950 |
| FDA Grants Fast Track Designation to Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer Patients with Bone Metastases. |
|
|
Aug 23, 2011 |
954 |
| Symphogen Announces Initiation of Phase 2 Trial of Sym004 EGFR Antibody Mixture in Patients with Squamous Cell Carcinoma of Head and Neck Cancer. |
|
|
Aug 23, 2011 |
698 |
| Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System. |
|
Clinical report |
Aug 22, 2011 |
1238 |
| Amgen Announces PDUFA Date for XGEVA Supplemental Biologics License Application. |
|
|
Aug 22, 2011 |
2224 |
| Research and Markets: FDA Approves Zytiga (Abiraterone Acetate) for the Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer. |
|
|
Aug 18, 2011 |
414 |
| Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat. |
|
|
Aug 17, 2011 |
766 |
| FDA Approves Zelboraf (Vemurafenib) and Companion Diagnostic for BRAF Mutation-Positive Metastatic Melanoma, a Deadly Form of Skin Cancer. |
|
|
Aug 17, 2011 |
1747 |
| Plexxikon Announces FDA Approval of Zelboraf[TM] (vemurafenib) and Companion Diagnostic for the Treatment of Patients with BRAF Mutation-Positive Metastatic Melanoma. |
|
|
Aug 17, 2011 |
1722 |
| Research and Markets: Metastatic Liver Cancer - Pipeline Review, Q3 2011. |
|
|
Aug 17, 2011 |
462 |
| University of Alabama at Birmingham Scientists Work to Uncover the Role of a Gene That May Trigger Breast Cancer Metastasis, with Research Funding from Susan G. Komen for the Cure[R]. |
|
|
Aug 16, 2011 |
558 |
| Research and Markets: Handbook of Metastatic Breast Cancer. |
|
|
Aug 12, 2011 |
277 |
| ApoCell Awarded $2.9 Million from SAIC-Frederick Inc. to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells (CTCs) to the National Cancer Institute's Pharmacodynamics Program. |
|
|
Aug 10, 2011 |
833 |
| Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome. |
|
Clinical report |
Aug 9, 2011 |
1435 |
| QIAGEN Completes Second U.S.Submission for Companion Diagnostic to Guide Treatment Decisions in Colorectal Cancer. |
|
|
Aug 5, 2011 |
1359 |
| New genetic markers for breast cancer metastasis identified. |
|
|
Aug 4, 2011 |
227 |
| Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma. |
|
Clinical report |
Aug 2, 2011 |
1257 |
| A biopsy diagnosis? Clinical clues and patterns to help distinguish cutaneous metastases: part II of II (*). |
|
Report |
Aug 1, 2011 |
4049 |
| Oncolytics Biotech Clinical Trial Reports Positive Results. |
|
|
Aug 1, 2011 |
429 |
| Research and Markets: Metastatic Brain Tumors Pipeline Review, Q2 2011 - Understand the Metastatic Brain Tumors Products Currently Under Development. |
|
|
Aug 1, 2011 |
482 |
| Publication: Study Demonstrates the Pathwork[R] Tissue of Origin Test Works with Body Fluid Specimens to Identify Metastatic Cancers. |
|
|
Aug 1, 2011 |
601 |
| Management of lateral cervical metastases in papillary thyroid cancer: patterns of lymph node distribution. |
King, J. Michael; Corbitt, Christian; Miller, Frank R. |
Clinical report |
Aug 1, 2011 |
2360 |
| Biocept, Inc. Announces Availability of Its New Breast Cancer Test, OncoCEE-BR(TM) Utilizing Circulating Tumor Cells (CTCs). |
|
|
Jul 28, 2011 |
1134 |
| Zytiga Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration Resistant Prostate Cancer. |
|
Disease/Disorder overview |
Jul 22, 2011 |
1364 |
| Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102. |
|
Clinical report |
Jul 22, 2011 |
897 |
| Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102. |
|
Clinical report |
Jul 22, 2011 |
910 |
| NCCN Breast Cancer Panel Reaffirms Current Position and Recommendation Regarding the Use of Bevacizumab in Metastatic Breast Cancer. |
|
|
Jul 19, 2011 |
625 |
| Draft Nice Guidance on Advanced Breast Cancer Treatment, Halaven(R) Black Triangle Drug (Eribulin). |
|
|
Jul 19, 2011 |
1669 |
| XGEVA (Denosumab) Granted Marketing Authorization in the European Union. |
|
|
Jul 15, 2011 |
2796 |
| Antitumor effect of Croatian propolis as a consequence of diverse sex-related dihydropyrimidine dehydrogenase (DPD) protein expression. |
Sobocanec, Sandra; Baloga, Tihomir; Saric, Ana; Macak-Safranko, Zeljka; Stroser, Marina; Zarkovicb, |
Report |
Jul 15, 2011 |
4690 |
| UCSF Study Published: Demonstrates High Accuracy of Pathwork[R] Tissue of Origin Test for Metastatic and Difficult to Diagnose Cancers. |
|
|
Jul 11, 2011 |
779 |
| Drug combo can benefit more than 1 in 3 with hard-to-treat breast cancer. |
|
|
Jul 9, 2011 |
252 |
| Phase 3 Trial of ZALTRAP(TM) (aflibercept) in Advanced Prostate Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee. |
|
|
Jul 7, 2011 |
1380 |
| Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE. |
|
|
Jul 6, 2011 |
1152 |
| Medicare to pay for Avastin regardless of FDA. |
|
|
Jul 3, 2011 |
205 |
| Coffee for the prostate? |
|
Brief article |
Jul 1, 2011 |
163 |
| Using communication skills for difficult conversations in palliative care: 'Suffering is not a question which demands an answer, it is not a problem which demands a solution, It is a mystery which demands a "Presence".' (Anonymous). |
Barnard, Alan; Ganca, Linda |
|
Jul 1, 2011 |
2078 |
| ACORN Research Reports Positive Findings of Phase 2b Metastatic Breast Cancer Trial at ASCO. |
|
Clinical report |
Jun 30, 2011 |
612 |
| Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE. |
|
|
Jun 30, 2011 |
1119 |
| Additional Data on Provectus's PV-10 for Metastatic Melanoma Presented at Prominent Melanoma Conferences. |
|
Conference news |
Jun 29, 2011 |
730 |
| Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer. |
|
|
Jun 29, 2011 |
2278 |
| Alternative Pain Therapy for Breast, Prostate and Lung Cancer. |
|
|
Jun 28, 2011 |
365 |
| DFINE Announces First Patient Treated with STAR[TM] System in a Clinical Trial to Evaluate Targeted Radiofrequency Ablation Therapy for Spinal Tumors. |
|
|
Jun 28, 2011 |
920 |
| Amgen Submits Application to Expand Indication for XGEVA (Denosumab) to Prevent or Delay Spread of Prostate Cancer to the Bone. |
|
|
Jun 27, 2011 |
2652 |
| Amgen Receives Positive CHMP Opinion for Vectibix (Panitumumab) in Combination With Chemotherapy. |
|
|
Jun 24, 2011 |
2857 |
| Drug used against tapeworm infection also inhibits colon cancer metastasis. |
|
|
Jun 18, 2011 |
249 |
| Nordion Awards Contract for Phase III Clinical Trials to Theorem Clinical Research. |
|
|
Jun 16, 2011 |
859 |
| Phase 2 Data on Provectus's PV-10 for Metastatic Melanoma to Be Presented at Two Upcoming Conferences. |
|
Conference news |
Jun 15, 2011 |
506 |
| Less depression, longer breast cancer survival. |
McNamara, Damian |
|
Jun 15, 2011 |
794 |
| Medicare Covers the Pathwork[R] Tissue of Origin Test: Helps Diagnose Metastatic and Other Difficult to Diagnose Cancers. |
|
|
Jun 13, 2011 |
579 |
| Why pregnancy ups cancer risk. |
|
|
Jun 11, 2011 |
204 |
| Aushon's Multiplex Immunoassay Platform Used to Validate Panel of Prognostic and Predictive Protein Biomarkers in Recent Phase II and Phase III Studies. |
|
|
Jun 10, 2011 |
334 |
| Metabolomics Study Provides Insight into Ovary Metabolome and Cancer-Associated Metabolic Changes Report Investigators from University of Louisville and Metabolon. |
|
|
Jun 9, 2011 |
432 |
| Key molecule behind breast cancer spread identified. |
|
|
Jun 9, 2011 |
237 |
| WORLDWIDE HEALTHCARE TRUST PLC - Annual Financial Report. |
|
Report |
Jun 9, 2011 |
31011 |
| New drug shows promise in stopping prostate cancer spread to bone. |
|
|
Jun 8, 2011 |
270 |
| Sphenoid sinus metastatic lesion from a pyriform fossa squamous cell carcinoma. |
Barrett, G.; Espeso, A.; Hickey, S.A. |
Case study |
Jun 8, 2011 |
1046 |
| OncoSec ElectroImmunotherapy Shows Systemic Effects of Metastatic Melanoma Tumor in More than 50% of Patients. |
|
|
Jun 7, 2011 |
1341 |
| Bio-Nucleonics Continues Production of Cancer Drug. |
|
|
Jun 7, 2011 |
407 |
| Ipsen announces discontinuation of the development of Irosustat in monotherapy. |
|
Clinical report |
Jun 6, 2011 |
1102 |
| Genesis Biopharma to Develop Autologous Cell Therapy for Metastatic Melanoma. |
|
|
Jun 6, 2011 |
678 |
| Symphogen Presents Results from the First Clinical Trial with Sym004 at ASCO. |
|
|
Jun 6, 2011 |
758 |
| Astellas Announces New Study Results Showing Increased Survival Rate for Metastatic Pancreatic Cancer. |
|
|
Jun 6, 2011 |
668 |
| Exelixis' Cabozantinib Phase 2 Data Demonstrate Encouraging Clinical Activity in Patients with Metastatic Castration-Resistant Prostate Cancer. |
|
|
Jun 6, 2011 |
2855 |
| Genentech Announces Vemurafenib Improved Survival in People With Metastatic Melanoma Who Have BRAF V600 Mutations. |
|
|
Jun 5, 2011 |
1865 |
| Targeted drug-combo shows promise in treating metastatic melanoma. |
|
|
Jun 4, 2011 |
178 |
| Exelixis' Cabozantinib Demonstrates Encouraging Clinical Activity in Patients with Metastatic Ovarian Cancer. |
|
|
Jun 4, 2011 |
1659 |
| Study Evaluating SIR-Spheres[R] Microspheres in Patients with Metastatic Breast Cancer Presented at the 2011 American Society of Clinical Oncology Annual Meeting. |
|
|
Jun 3, 2011 |
708 |
| Silicon Biosystems Announces Abstracts Accepted for the 2011 ASCO Annual Meeting. |
|
|
Jun 3, 2011 |
599 |
| Celgene and Acceleron Initiate Phase 2/3 Study of ACE-011 (sotatercept) to Treat Chemotherapy-Induced Anemia in Patients with Lung Cancer. |
|
|
Jun 2, 2011 |
869 |
| Johnson & Johnson's Zytiga is Forecasted to Earn Peak Year Sales of $910 Million for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. |
|
|
Jun 2, 2011 |
503 |
| Morphotek, Inc. Announces Initiation of MORAb-004 Phase II Study in Melanoma. |
|
Clinical report |
Jun 2, 2011 |
1152 |
| Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat. |
|
|
Jun 2, 2011 |
679 |
| Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs). |
|
|
Jun 2, 2011 |
842 |
| MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients. |
|
|
Jun 2, 2011 |
808 |
| Recent developments in kidney cancer. |
Leveridge, Michael J.; Jewett, Michael A. S. |
Clinical report |
Jun 1, 2011 |
8599 |
| A biopsy diagnosis? clinical clues and patterns to help distinguish cutaneous metastases: Part I of II. |
Blecher, Karin; Friedman, Adam |
Report |
Jun 1, 2011 |
3461 |
| Does surgery improve survival in stage IV breast cancer? |
Khan, Seema; Cady, Blake |
|
Jun 1, 2011 |
1361 |
| Screen breast cancer patients for depression: from the annual meeting of the American Psychiatric Association. |
McNamara, Damian |
|
Jun 1, 2011 |
723 |
| Leiomyosarcoma in a sheep: a case report. |
Javadi, Afshin; Mohajeri, Daryoush; Nazeri, Mehrdad |
Report |
Jun 1, 2011 |
2052 |
| Tragara Pharmaceuticals' Apricoxib Reverses EMT, a Key Process for Cancer Progression and Metastasis. |
|
|
May 26, 2011 |
1194 |
| Abiraterone Acetate Significantly Improves Overall Survival of Patients With Post-Chemotherapy Metastatic Castration-Resistant Prostate Cancer. |
|
Clinical report |
May 25, 2011 |
1634 |
| Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA(TM) (abiraterone acetate). |
|
Clinical report |
May 25, 2011 |
1516 |
| New Breast Cancer Treatment Launched in UK. |
|
|
May 24, 2011 |
1505 |
| VBL Therapeutics To Present Updated Clinical Results for VB-111 at 2011 ASCO Annual Meeting. |
|
Clinical report |
May 23, 2011 |
927 |
| Amgen Receives CHMP Positive Opinion for XGEVA(TM) (Denosumab) in the European Union. |
|
|
May 20, 2011 |
2661 |
| Amgen Receives CHMP Positive Opinion for XGEVA(TM) (Denosumab) in the European Union. |
|
|
May 20, 2011 |
2680 |
| SUTENT[R] Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors. |
|
|
May 20, 2011 |
1799 |
| Plexxikon Announces Data Presentations of Oncology Pipeline, Including Phase 3 Vemurafenib Data, at ASCO 2011 Annual Meeting. |
|
|
May 19, 2011 |
1570 |
| Enzon Announces Discontinuation of PEG-SN38 Program in Metastatic Colorectal Carcinoma in Light of Evolving Standards of Care. |
|
|
May 19, 2011 |
622 |
| CTC blood test most 'powerful predictor' of metastatic breast cancer. |
|
|
May 19, 2011 |
260 |
| VBL Therapeutics Presents Preclinical Data for VB-111 at the 14th Annual ASGCT Meeting. |
|
|
May 19, 2011 |
706 |
| Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting. |
|
|
May 19, 2011 |
792 |
| Research and Markets: Bone Metastases Therapeutics - Strong Pipeline is Likely to Result in Steep Growth for the Market. |
|
|
May 18, 2011 |
449 |
| Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting. |
|
|
May 18, 2011 |
933 |
| Dendreon Announces Presentation of PROVENGE Data at the 2011 American Society of Clinical Oncology Annual Meeting. |
|
Clinical report |
May 18, 2011 |
996 |
| Majority of Physicians Using Herceptin as Key Therapy for Gastric Cancer, But Satisfaction With Treatment Options Remains Low, According to Oncology Tracking Study by GfK HealthCare. |
|
Report |
May 17, 2011 |
594 |
| Intermountain Healthcare Establishes Reimbursement Coverage Policy for Pathwork Diagnostics' Tissue of Origin Test. |
|
|
May 17, 2011 |
595 |
| Denosumab May Prolong Metastasis-Free Survival in Men with High-Risk Prostate Cancer. |
|
|
May 17, 2011 |
716 |
| Eisai's Eribulin (Halaven(R)) Receives Swissmedic Approval for use in Locally Advanced and Metastatic Breast Cancer. |
|
|
May 17, 2011 |
1690 |
| Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients. |
|
|
May 12, 2011 |
1225 |
| Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients. |
|
|
May 12, 2011 |
1236 |
| Cytheris, Centre Leon Berard and ImmunID Announce Initiation of Clinical Trial to Evaluate Combination Regimen of IL-7 (CYT107) and XELODA[R] (capecitabine) in Treatment of Metastatic Breast Cancer. |
|
|
May 11, 2011 |
2366 |
| Bad protein cuts good protein in prostate cancer development. |
|
|
May 11, 2011 |
287 |
| First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders. |
|
|
May 10, 2011 |
927 |
| Debra M. LeDuc Meadows. |
|
|
May 10, 2011 |
360 |
| Rosetta Genomics Announces Issuance of Additional U.S. Patent. |
|
|
May 9, 2011 |
1409 |
| FDA Approves New Treatment for Rare Type of Pancreatic Cancer. |
|
|
May 6, 2011 |
652 |
